High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses.
Adult
Aged
Bone Diseases, Developmental
/ epidemiology
Ciliopathies
/ epidemiology
Cytoplasmic Dyneins
/ genetics
Cytoskeletal Proteins
/ genetics
Female
Genetic Predisposition to Disease
Genome, Human
/ genetics
High-Throughput Nucleotide Sequencing
Humans
Intercellular Signaling Peptides and Proteins
/ genetics
Intracellular Signaling Peptides and Proteins
/ genetics
Male
Membrane Proteins
/ genetics
Microtubule-Associated Proteins
/ genetics
Middle Aged
Muscle, Skeletal
/ metabolism
Protein Isoforms
/ genetics
Whole Genome Sequencing
Journal
Journal of human genetics
ISSN: 1435-232X
Titre abrégé: J Hum Genet
Pays: England
ID NLM: 9808008
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
04
12
2020
accepted:
31
03
2021
revised:
31
03
2021
pubmed:
21
4
2021
medline:
20
1
2022
entrez:
20
4
2021
Statut:
ppublish
Résumé
Skeletal ciliopathies are a heterogenous group of disorders with overlapping clinical and radiographic features including bone dysplasia and internal abnormalities. To date, pathogenic variants in at least 30 genes, coding for different structural cilia proteins, are reported to cause skeletal ciliopathies. Here, we summarize genetic and phenotypic features of 34 affected individuals from 29 families with skeletal ciliopathies. Molecular diagnostic testing was performed using massively parallel sequencing (MPS) in combination with copy number variant (CNV) analyses and in silico filtering for variants in known skeletal ciliopathy genes. We identified biallelic disease-causing variants in seven genes: DYNC2H1, KIAA0753, WDR19, C2CD3, TTC21B, EVC, and EVC2. Four variants located in non-canonical splice sites of DYNC2H1, EVC, and KIAA0753 led to aberrant splicing that was shown by sequencing of cDNA. Furthermore, CNV analyses showed an intragenic deletion of DYNC2H1 in one individual and a 6.7 Mb de novo deletion on chromosome 1q24q25 in another. In five unsolved cases, MPS was performed in family setting. In one proband we identified a de novo variant in PRKACA and in another we found a homozygous intragenic deletion of IFT74, removing the first coding exon and leading to expression of a shorter message predicted to result in loss of 40 amino acids at the N-terminus. These findings establish IFT74 as a new skeletal ciliopathy gene. In conclusion, combined single nucleotide variant, CNV and cDNA analyses lead to a high yield of genetic diagnoses (90%) in a cohort of patients with skeletal ciliopathies.
Identifiants
pubmed: 33875766
doi: 10.1038/s10038-021-00925-x
pii: 10.1038/s10038-021-00925-x
pmc: PMC8472897
doi:
Substances chimiques
C2cd3 protein, human
0
Cytoskeletal Proteins
0
DYNC2H1 protein, human
0
EVC protein, human
0
EVC2 protein, human
0
Intercellular Signaling Peptides and Proteins
0
Intracellular Signaling Peptides and Proteins
0
KIAA0753 protein, human
0
Membrane Proteins
0
Microtubule-Associated Proteins
0
Protein Isoforms
0
TTC21B protein, human
0
WDR19 protein, human
0
Cytoplasmic Dyneins
EC 3.6.4.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
995-1008Subventions
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 2018-03046
Informations de copyright
© 2021. The Author(s).
Références
Am J Med Genet A. 2013 Nov;161A(11):2762-76
pubmed: 24123776
Am J Med Genet A. 2011 May;155A(5):1021-32
pubmed: 21465651
J Bone Miner Res. 2018 Apr;33(4):753-760
pubmed: 29178448
Am J Med Genet A. 2019 Dec;179(12):2393-2419
pubmed: 31633310
J Pathol. 2017 Jan;241(2):294-309
pubmed: 27859258
Am J Hum Genet. 2011 Nov 11;89(5):634-43
pubmed: 22019273
Nat Genet. 2016 Jun;48(6):648-56
pubmed: 27158779
Nature. 2003 Nov 6;426(6962):83-7
pubmed: 14603322
Am J Hum Genet. 2009 May;84(5):706-11
pubmed: 19442771
Am J Hum Genet. 2009 Apr;84(4):542-9
pubmed: 19361615
Eur J Med Genet. 2020 Apr;63(4):103823
pubmed: 31816441
Hum Mutat. 2018 Oct;39(10):1456-1467
pubmed: 30080953
Am J Hum Genet. 2015 Nov 5;97(5):744-53
pubmed: 26477546
Nat Genet. 2011 Mar;43(3):189-96
pubmed: 21258341
J Med Genet. 2015 Dec;52(12):830-9
pubmed: 26386044
Am J Med Genet A. 2017 Jun;173(6):1698-1704
pubmed: 28422394
Hum Mol Genet. 2016 Sep 15;25(18):3998-4011
pubmed: 27466187
Eur J Hum Genet. 2020 Jul;28(7):943-946
pubmed: 32144365
Sci Rep. 2016 Apr 20;6:24083
pubmed: 27094867
Am J Med Genet A. 2015 May;167A(5):1008-17
pubmed: 25728055
J Med Genet. 2017 Jun;54(6):371-380
pubmed: 28289185
Am J Hum Genet. 2014 Jan 2;94(1):62-72
pubmed: 24360808
Clin Genet. 2015 Dec;88(6):550-7
pubmed: 25492405
Hum Genet. 2017 Apr;136(4):399-408
pubmed: 28220259
Hum Genet. 2013 Aug;132(8):865-84
pubmed: 23559409
Genome Med. 2019 Nov 7;11(1):68
pubmed: 31694722
Sci Transl Med. 2017 Apr 19;9(386):
pubmed: 28424332
Hum Mutat. 2013 May;34(5):714-24
pubmed: 23418020
Nat Genet. 2014 Aug;46(8):905-11
pubmed: 24997988
Nat Genet. 2000 Mar;24(3):283-6
pubmed: 10700184
Am J Hum Genet. 2016 Aug 4;99(2):318-36
pubmed: 27486776
Clin Genet. 2014 Jun;85(6):592-4
pubmed: 23826986
J Med Genet. 2013 May;50(5):309-23
pubmed: 23456818
Hum Mol Genet. 2016 Feb 1;25(3):497-513
pubmed: 26643951
Sci Rep. 2016 Sep 26;6:34232
pubmed: 27666822
Hum Mol Genet. 2016 May 1;25(9):1824-35
pubmed: 26908619
Annu Rev Biochem. 2015;84:291-323
pubmed: 25784052
J Med Genet. 2015 Aug;52(8):514-22
pubmed: 26092869
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Sci Rep. 2017 Nov 14;7(1):15585
pubmed: 29138412
J Cell Sci. 2016 May 15;129(10):2106-19
pubmed: 27068536
Congenit Anom (Kyoto). 2015 Aug;55(3):155-7
pubmed: 25410398
Am J Hum Genet. 2020 Nov 5;107(5):977-988
pubmed: 33058759
Nat Commun. 2017 Jun 12;8:15824
pubmed: 28604674
Hum Mutat. 2018 Jan;39(1):152-166
pubmed: 29068549